Literature DB >> 15573182

Age distribution of nasopharyngeal cancer in Saudi Arabia.

Abdulwahab A Andejani1, Vijayananda Kundapur, Kamal Malaker.   

Abstract

OBJECTIVE: The age standardized rate of head and neck cancer in the Kingdom of Saudi Arabia (KSA) is 5.7% with nasopharyngeal cancer (NPC) accounting for >40% of all head and neck cancers. This study intends to compare age specific incidence of NPC in KSA and other countries.
METHODS: Data from the National Cancer Registry for KSA during the period 1994 through to 1996 was compared with data from the World Health Organization International Agency for Research on Cancer (ARC) in Singapore, China, Kuwait and Canada.
RESULTS: There were 373 diagnosed Saudi patients with NPC with high incidence among the young population, with 42/373 (22 males/20 females) patients in the first 20 years of life, showing a sharp increase both in boys and girls until the ages of 12-14 years. From that point the incidence curve for both males and females separates. In females the incidence flattens without an identifiable zenith from the age of 12-14 years and above, compared with their male counterpart where they have another peak in the fifth decade.
CONCLUSION: Our study indicates a definite early onset of this malignancy in KSA and a similar pattern to that of China and Singapore. Definite increased incidence, at a young age among both sexes, suggests a possible underlying genetic susceptibility in Saudis.

Entities:  

Mesh:

Year:  2004        PMID: 15573182

Source DB:  PubMed          Journal:  Saudi Med J        ISSN: 0379-5284            Impact factor:   1.484


  2 in total

1.  Nasopharyngeal carcinoma in a south European population: epidemiological data and clinical aspects in Portugal.

Authors:  Breda Eduardo; Catarino Raquel; Medeiros Rui
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-05-08       Impact factor: 2.503

2.  Outcomes of Saudi Arabian Patients With Nasopharyngeal Cancer Treated With Primarily Neoadjuvant Chemotherapy Followed by Concurrent Chemoradiotherapy.

Authors:  Rolina Al-Wassia; Atlal Abusanad; Nesreen Awad; Hani Marzouki; Shadi Alkhayyat; Talal Al-Khatib; Camelia Constantinescu
Journal:  J Glob Oncol       Date:  2016-02-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.